The novel therapy of the medication represents a exciting breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment